Oncology | Precision Medicine | Radiology Explainable Precision Medicine in Breast MRI: A Combined Radiomics and Deep Learning Approach for the Classification of Contrast Agent Uptake. June 27, 2024
Oncology | Radiology Integrating intratumoral and peritumoral radiomics with deep transfer learning for DCE-MRI breast lesion differentiation: A multicenter study comparing performance with radiologists. June 14, 2024
Oncology | Radiology Study on the differential diagnosis of benign and malignant breast lesions using a deep learning model based on multimodal images. April 30, 2024
Oncology | Radiology A Deep Learning Model for Predicting Molecular Subtype of Breast Cancer by Fusing Multiple Sequences of DCE-MRI From Two Institutes. April 18, 2024
Oncology | Radiology Lymph node metastasis prediction and biological pathway associations underlying DCE-MRI deep learning radiomics in invasive breast cancer. April 16, 2024
Oncology | Radiology Combination of DCE-MRI and NME-DWI via Deep Neural Network for Predicting Breast Cancer Molecular Subtypes. March 30, 2024
Medical Imaging | Radiology Unpaired deep learning for pharmacokinetic parameter estimation from dynamic contrast-enhanced MRI without AIF measurements. March 22, 2024
Medical Imaging | Oncology | Radiology TPA: Two-stage progressive attention segmentation framework for hepatocellular carcinoma on multi-modality MRI. February 2, 2024
Neurology | Oncology | Radiology Added value of dynamic contrast-enhanced MR imaging in deep learning-based prediction of local recurrence in grade 4 adult-type diffuse gliomas patients. January 25, 2024
Medical Imaging | Radiology Greybox: A hybrid algorithm for direct estimation of tracer kinetic parameters from undersampled DCE-MRI data. January 12, 2024
Oncology | Radiology MRI-Based Kinetic Heterogeneity Evaluation in the Accurate Access of Axillary Lymph Node Status in Breast Cancer Using a Hybrid CNN-RNN Model. January 11, 2024
Imaging | Oncology | Radiology Breast Multiparametric MRI for Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: The BMMR2 Challenge. January 5, 2024